Journal Article10.1007/S00246-014-1032-1
Common Variants in the CRP Promoter are Associated with a High C-Reactive Protein Level in Kawasaki Disease
Jae-Jung Kim,Sin Weon Yun,Jeong Jin Yu,Kyung Lim Yoon,Kyung-Yil Lee,Hong Ryang Kil,Gi Beom Kim,Myung Ki Han,Min Seob Song,Hyoung Doo Lee,Jung Hye Byeon,Saejung Sohn,Young Mi Hong,Gi Young Jang,Jong-Keuk Lee +14 more
17
TL;DR: It is indicated that common variants in the CRP promoter can play an important role in theCRP levels in KD patients and did not affect the development of coronary artery lesions or intravenous immunoglobulin resistance in KD Patients.
read more
Abstract: Kawasaki disease (KD) is an acute self-limiting form of vasculitis that afflicts infants and children and manifests as fever and signs of mucocutaneous inflammation. Children with KD show various laboratory inflammatory abnormalities, such as elevations in their white blood cell (WBC) count, C-reactive protein (CRP) level, and erythrocyte sedimentation rate (ESR). We here performed a genome-wide association study (GWAS) of 178 KD patients to identify the genetic loci that influence 10 important KD laboratory markers: WBC count, neutrophil count, platelet count, CRP, ESR, hemoglobin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), albumin, and total protein. A total of 165 loci passed our arbitrary stage 1 threshold for replication (p < 1 × 10(-5)). Of these, only 2 SNPs (rs12068753 and rs4786091) demonstrated a significant association with the CRP level in replication study of 473 KD patients (p < 0.05). The SNP located at the CRP locus (rs12068753) demonstrated the most significant association with CRP in KD patients (beta = 4.73 and p = 1.20 × 10(-6) according to the stage 1 GWAS; beta = 3.65 and p = 1.35 × 10(-8) according to the replication study; beta = 3.97 and p = 1.11 × 10(-13) according to combined analysis) and explained 8.1% of the phenotypic variation observed. However, this SNP did not demonstrate any significant association with CRP in the general population (beta = 0.37 and p = 0.1732) and only explained 0.1% of the phenotypic variation in this instance. Furthermore, rs12068753 did not affect the development of coronary artery lesions or intravenous immunoglobulin resistance in KD patients. These results indicate that common variants in the CRP promoter can play an important role in the CRP levels in KD.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians
TL;DR: This critical state-of-the-art monography provides all the crucial data on the potential biochemical properties of the protein, along with further evidence on its potential pathobiology, including information for its ligands as well as the possible function of autoantibodies against the protein.
50
Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis.
TL;DR: Pediatric patients with IVIG resistant were more likely to develop CAA within 1 month of the onset of KD than the general population, even in patients with other risk factors for CAA, suggesting a potential risk of CAA misdiagnosis if echocardiography is not carried out frequently.
Vasculitis Pathogenesis: Can We Talk About Precision Medicine?
Seza Ozen,Ezgi Deniz Batu +1 more
TL;DR: Genome-wide association studies (GWAS) data, lessons from monogenic mimics of these diseases, and biomarker studies in immunoglobulin A vasculitis/Henoch–Schönlein purpura, Kawasaki disease, anti-neutrophil cytoplasmic antibody-associated Vasculitis, polyarteritis nodosa (PAN), Takayasu arteritis, and Behçet's disease are reviewed.
Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.
Bin Tang,Hang Hong Lo,Cheng Lei,Ka In U,W.L. Wendy Hsiao,Xiaoling Guo,Jun Bai,Vincent Kam Wai Wong,Betty Yuen Kwan Law +8 more
TL;DR: It is anticipated that novel therapeutic remedies, especially active herbal chemicals targeting precise clinical markers of KD could be developed for accurate diagnosis and treatment of the disease.
20
Protein prediction for trait mapping in diverse populations
TL;DR: This article used the Trans-omics for Precision Medicine (TOPMed) multi-omics pilot study, which comprises data from Multi-Ethnic Study of Atherosclerosis (MESA), to optimize genetic predictors of the plasma proteome for genetically regulated proteomewide association studies (PWAS) in diverse populations.
References
PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses
Shaun Purcell,Shaun Purcell,Benjamin M. Neale,Benjamin M. Neale,Kathe Todd-Brown,Lori Thomas,Manuel A. R. Ferreira,David Bender,David Bender,Julian Maller,Julian Maller,Pamela Sklar,Pamela Sklar,Paul I.W. de Bakker,Paul I.W. de Bakker,Mark J. Daly,Mark J. Daly,Pak C. Sham +17 more
TL;DR: This work introduces PLINK, an open-source C/C++ WGAS tool set, and describes the five main domains of function: data management, summary statistics, population stratification, association analysis, and identity-by-descent estimation, which focuses on the estimation and use of identity- by-state and identity/descent information in the context of population-based whole-genome studies.
33.2K
Atherosclerosis — An Inflammatory Disease
TL;DR: Atherosclerosis is an inflammatory disease as discussed by the authors, and it is a major cause of death in the United States, Europe, and much of Asia, despite changes in lifestyle and use of new pharmacologic approaches to lower plasma cholesterol concentrations.
21.2K
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
Jane W. Newburger,Masato Takahashi,Michael A. Gerber,Michael H. Gewitz,Lloyd Y. Tani,Jane C. Burns,Stanford T. Shulman,Ann F. Bolger,Patricia Ferrieri,Robert S. Baltimore,Walter R. Wilson,Larry M. Baddour,Matthew E. Levison,Thomas J. Pallasch,Donald A. Falace,Kathryn A. Taubert +15 more
TL;DR: Recommendations for the initial evaluation, treatment in the acute phase, and long-term management of patients with Kawasaki disease are intended to assist physicians in understanding the range of acceptable approaches for caring for patients withawasaki disease.
Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association
Jane W. Newburger,Masato Takahashi,Michael A. Gerber,Michael H. Gewitz,Lloyd Y. Tani,Jane C. Burns,Stanford T. Shulman,Ann F. Bolger,Patricia Ferrieri,Robert S. Baltimore,Walter R. Wilson,Larry M. Baddour,Matthew E. Levison,Thomas J. Pallasch,Donald A. Falace,Kathryn A. Taubert +15 more
TL;DR: A new algorithm is proposed to aid clinicians in deciding which children with fever for ≥5 days and ≤4 classic criteria should undergo electrocardiography, receive intravenous gamma globulin (IVIG) treatment, or both for Kawasaki disease.
1.6K
Related Papers (5)
[...]
Chiea Chuen Khor,Chiea Chuen Khor,Sonia Davila,Sonia Davila,Willemijn B. Breunis,Yi-Ching Lee,Chisato Shimizu,Chisato Shimizu,Victoria J. Wright,Rae S. M. Yeung,Dennis E.K. Tan,Kar Seng Sim,Jie Jin Wang,Jie Jin Wang,Tien Yin Wong,Tien Yin Wong,Tien Yin Wong,Junxiong Pang,Junxiong Pang,Paul Mitchell,Rolando Cimaz,Nagib Dahdah,Yiu-fai Cheung,Guo Ying Huang,Wanling Yang,In Sook Park,Jong-Keuk Lee,Jer-Yuarn Wu,Michael Levin,Jane C. Burns,Jane C. Burns,David Burgner,David Burgner,Taco W. Kuijpers,Martin L. Hibberd,Martin L. Hibberd,Yu-Lung Lau,Jing Zhang,Xiao Jing Ma,Fang Liu,Lin Wu,Jeong Jin Yoo,Soo-Jong Hong,Kwi Joo Kim,Jae-Jung Kim,Young-Mi Park,Young Mi Hong,Sejung Sohn,Gi Young Jang,Kee Soo Ha,Hyo Kyoung Nam,Jung Hye Byeon,Sin Weon Yun,Myung Ki Han,Kyung-Yil Lee,Ja Young Hwang,Jung Woo Rhim,Min Seob Song,Hyoung Doo Lee,Dong Soo Kim,Jae Moo Lee,Jeng Sheng Chang,Fuu Jen Tsai,Chi Di Liang,Ming-Ren Chen,Hsin Chi,Nan Chang Chiu,Fu Yuan Huang,Luan-Yin Chang,Li-Min Huang,Ho-Chang Kuo,Kao Pin Huang,Meng Luen Lee,Betau Hwang,Yhu Chering Huang,Pi Chang Lee,Miranda Odam,Miranda Odam,Frank T. Christiansen,Campbell S. Witt,Paul N. Goldwater,Paul N. Goldwater,Nigel Curtis,Nigel Curtis,Pamela Palasanthiran,John B. Ziegler,Michael D. Nissen,Clare Nourse,Irene M. Kuipers,J Ottenkamp,Judy Geissler,Maarten H Biezeveld,Carline E. Tacke,Luc Filippini,Paul A. Brogan,Nigel Klein,Vanita Shah,M J Dillon,Robert Booy,Delane Shingadia,Anu Bose,Thomas Mukasa,Robert Tulloh,Colin Michie,Jane W. Newburger,Annette L. Baker,Anne H. Rowley,Stanford T. Shulman,Wilbert H. Mason,Masato Takahashi,Marian E. Melish,Adriana H. Tremoulet,Ananth C. Viswanathan,Elena Rochtchina,John Attia,Rodney J. Scott,Elizabeth G. Holliday,Stephen B. Harrap +117 more
Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis
[...]
Yi-Ching Lee,Yi-Ching Lee,Ho-Chang Kuo,Ho-Chang Kuo,Jeng Sheng Chang,Luan-Yin Chang,Li-Min Huang,Ming-Ren Chen,Chi-Di Liang,Chi-Di Liang,Hsin Chi,Fu-Yuan Huang,Meng-Luen Lee,Yhu-Chering Huang,Yhu-Chering Huang,Betau Hwang,Nan-Chang Chiu,Kao-Pin Hwang,Kao-Pin Hwang,Pi-Chang Lee,Li-Ching Chang,Yi-Min Liu,Ying Ju Chen,Chien Hsiun Chen,Chien Hsiun Chen,Yuan-Tsong Chen,Yuan-Tsong Chen,Fuu Jen Tsai,Fuu Jen Tsai,Jer-Yuarn Wu,Jer-Yuarn Wu +30 more
Jae-Jung Kim,Young Mi Hong,Saejung Sohn,Gi Young Jang,Kee-Soo Ha,Sin Weon Yun,Myung Ki Han,Kyung-Yil Lee,Min Seob Song,Hyoung Doo Lee,Dong Soo Kim,Jong Eun Lee,Eun-Soon Shin,Ji-Hyun Jang,Yeon-Su Lee,Sook-Young Kim,Jong-Young Lee,Bok-Ghee Han,Jer-Yuarn Wu,Kwi-Joo Kim,Young-Mi Park,Eul-Joo Seo,In Sook Park,Jong-Keuk Lee +23 more